Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients
Authors (first, second and last of 5)
Volume 11, issue 1, December 2021
130 articles in this issue
-
-
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
Authors (first, second and last of 10)
-
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
Authors (first, second and last of 8)
-
Magnetic nanoparticles in theranostics of malignant melanoma
Authors (first, second and last of 5)
This is part of 1 collection:
-
First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer
Authors (first, second and last of 7)
-
Amyloid PET quantification using low-dose CT-guided anatomic standardization
Authors (first, second and last of 6)
-
L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas
Authors (first, second and last of 13)
This is part of 1 collection:
-
Detection of the sentinel lymph node with hybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study
Authors (first, second and last of 14)
-
Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease
Authors (first, second and last of 10)
-
Imaging pheochromocytoma in small animals: preclinical models to improve diagnosis and treatment
Authors (first, second and last of 7)
This is part of 1 collection:
-
Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma
Authors (first, second and last of 13)
This is part of 1 collection:
-
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer
Authors (first, second and last of 11)
This is part of 1 collection:
-
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT
Authors (first, second and last of 6)
-
Comparison of [18F] NaF PET/CT dynamic analysis methods and a static analysis method including derivation of a semi-population input function for site-specific measurements of bone formation in a population with chronic kidney disease-mineral and bone disorder
Authors (first, second and last of 5)
-
Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
Authors (first, second and last of 5)
-
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Authors (first, second and last of 12)
-
[68Ga]Ga-4HMSA a promising new PET tracer for imaging inflammation
Authors (first, second and last of 4)
-
Dose escalation biodistribution, positron emission tomography/computed tomography imaging and dosimetry of a highly specific radionuclide-labeled non-blocking nanobody
Authors (first, second and last of 10)
-
More fat, less migration: breast density as a predictor of sentinel lymph node non-visualization in breast cancer
Authors (first, second and last of 4)
-
-
Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
Authors (first, second and last of 5)
-
Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis
Authors (first, second and last of 12)
-
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT
Authors (first, second and last of 6)
-
Short-duration dynamic [18F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [18F]DCFPyL PET/MR at 120 minutes
Authors (first, second and last of 13)
-
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography
Authors (first, second and last of 10)
-
Convolutional neural network-based automatic heart segmentation and quantitation in 123I-metaiodobenzylguanidine SPECT imaging
Authors (first, second and last of 6)
-
Rationale for MYC imaging and targeting in pancreatic cancer
Authors (first, second and last of 4)
This is part of 1 collection:
-
Alteration of neuroinflammation detected by 18F-GE180 PET imaging in place-conditioned rats with morphine withdrawal
Authors (first, second and last of 9)
-
-
Correction to: Biokinetics, dosimetry and radiation risk in infants after 99mTc-MAG3 scans
Authors (first, second and last of 5)
-
The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
Authors (first, second and last of 9)
-
Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity
Authors (first, second and last of 11)
-
Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network
Authors (first, second and last of 4)
-
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET
Authors (first, second and last of 9)
-
Lung shunt fraction calculation using 99mTc-MAA SPECT/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors
Authors (first, second and last of 6)
-
The effect of eating on the uptake of PSMA ligands in the salivary glands
Authors (first, second and last of 5)
-
Imaging modalities for diagnosis and monitoring of cancer cachexia
Authors (first, second and last of 8)
This is part of 1 collection:
-
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study
Authors (first, second and last of 11)
-
[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study
Authors (first, second and last of 8)
-
CERMEP-IDB-MRXFDG: a database of 37 normal adult human brain [18F]FDG PET, T1 and FLAIR MRI, and CT images available for research
Authors (first, second and last of 10)
-
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma
Authors (first, second and last of 7)
-
Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study
Authors (first, second and last of 4)
-
The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors
Authors (first, second and last of 9)
-
The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis
Authors (first, second and last of 8)
-
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis
Authors (first, second and last of 11)
-
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases
Authors (first, second and last of 11)
-
A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial
Authors (first, second and last of 10)
-
Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted
Authors (first, second and last of 7)
This is part of 1 collection:
-
Sex correction improves the accuracy of clinical dopamine transporter imaging
Authors (first, second and last of 8)
-
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
Authors (first, second and last of 7)
